ArticleAJPM focus2026
Exploring Sexually Transmitted and Bloodborne Infection Rates in Florida After Implementation of Syringe Services Programs: A Quasi-Experimental Study.
Article in AJPM focus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Introduction: The aim of this study was to evaluate the associations between syringe services program implementation and sexually transmitted and blood-borne infection rates in Florida counties. Methods: A difference-in-difference analysis was conducted using surveillance data (2010-2023) to compare sexually transmitted and blood-borne infection rates, including nonviral sexually transmitted infections (i.e., chlamydia, gonorrhea, infectious syphilis), acute hepatitis C virus, and HIV, before and after syringe services program implementation in Florida counties with operational syringe services programs versus control counties without syringe services programs. Two-way fixed-effects models were used to estimate average treatment effects, and multiple sensitivity analyses explored the robustness of the results. Results: Syringe services program implementation was associated with significant reductions in HIV rates (-11 per 100,000; 95% CI= -15.4, -6.7 in Miami-Dade County vs control counties), and hepatitis C virus rates appeared stable, whereas nonviral sexually transmitted infection rates appeared to increase. Conclusions: Syringe services programs appear to be effective in reducing HIV at the population level in Florida. The observed increase in sexually transmitted infection rates may reflect improved detection facilitated by syringe services programs and linkage to other care. Findings support the expansion of syringe services programs as a public health strategy and highlight the need for research on their broader population-level impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.